Abnormalp53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

Author:

Bosari Silvano,Lee Arthur K. C.,Viale Giuseppe,Heatley Gerald J.,Coggi Guido

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine,Pathology and Forensic Medicine

Reference36 articles.

1. Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla Palma P, Doglioni C (1992) Tumor suppressor gene product, proliferation and differentiation markers in lung neuroendocrine neoplasms. J Pathol 166:343–350

2. Bartek J, Iggo R, Gannon J, Lane DP (1990) Genetic and immunochemical analysis of mutantp53 in human cancer cell lines. Oncogene 5:893–899

3. Bartek J, Bartkova J, Vojtesk B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP (1991) Aberrant expression of thep53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703

4. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 9:359–377

5. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silver-man ML (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3